FDA Clearance Tracker · P220025
LimFlow System
Last checked: Nov 19, 2026Latest source record: Sep 11, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Sep 11, 2023
Approved
Time to decision
315 days
Received Oct 31, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P220025
- Device name
- LimFlow System
- Applicant
- LimFlow, Inc.
- Applicant location
- San Jose, CA
- Received
- Oct 31, 2022
- Decided
- Sep 11, 2023
- Decision
- Approved
- Supplements
- 8 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for The LimFlow System. The device is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QWN (Stent graft, infrapopliteal, venous arterialization).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
Other decisions for LimFlow, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- LimFlow Vector510(k)
K260188 · Decided Mar 18, 2026 · 55 days after receipt
Device type: Valvulotome (MGZ) · Cardiology
- LimFlow ARC510(k)
K251376 · Decided May 31, 2025 · 29 days after receipt
Device type: Catheter For Crossing Total Occlusions (PDU) · Cardiology
- LimFlow V-Ceiver510(k)
K242776 · Decided Feb 14, 2025 · 154 days after receipt
Device type: Device, Percutaneous Retrieval (MMX) · Cardiology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.